Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. vs 74.7%, p=0.50).

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

DAIC

APRIL 30, 2024

SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. and 3.8%, respectively.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

DAIC

JANUARY 29, 2024

The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.

Research 111

Research TAVR Aortic valve Medicare 111

DAIC

FEBRUARY 29, 2024

12:15 p.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24 24 and how those may impact clinical practice and patient care in this deep dive clinical trial session.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

The findings are particularly relevant considering the increasing adoption of bioprosthetic surgical valves in many patients and the recent trend of bioprosthetic transcatheter aortic valve replacement (TAVR) in younger populations without clear evidence.

Aortic valve 75

Aortic valve Aortic Cardiothoracic Cancer 75

Stroke Journal

JANUARY 30, 2025

Background:Despite improvements in the safety of transcatheter aortic valve replacement (TAVR), ~4% of patients experience a procedure-related stroke. TAVR seems to be preferred in patients with cancer; however, related research on the clinical efficacy and stroke outcomes of TAVR in patients with cancer is limited.

Aortic valve 40

Aortic valve Cancer Aortic Stenosis 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Laurie Shroyer Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes The Annals of Thoracic Surgery May 2018 Thomas Schwann Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting The Annals of Thoracic Surgery April 2018 Alexander Brescia Determinants of Variation in Pneumonia (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52